Hemoglobin A1c Accurately Predicts Continuous Glucose Monitoring-Derived Average Glucose in Youth and Young Adults With Cystic Fibrosis

被引:43
作者
Chan, Christine L. [1 ]
Hope, Emma [1 ]
Thurston, Jessica [1 ,2 ]
Vigers, Timothy [1 ]
Pyle, Laura [1 ,2 ]
Zeitler, Philip S. [1 ]
Nadeau, Kristen J. [1 ]
机构
[1] Univ Colorado, Childrens Hosp Colorado, Dept Pediat, Div Pediat Endocrinol, Anschutz Med Campus, Aurora, CO 80045 USA
[2] Colorado Sch Publ Hlth, Dept Biostat, Aurora, CO USA
基金
美国国家卫生研究院;
关键词
MEAN PLASMA-GLUCOSE; GLYCEMIC VARIABILITY; GLYCATED HEMOGLOBIN; SCREENING TOOL; HYPERGLYCEMIA; ALBUMIN; HBA(1C); TYPE-1; 1,5-ANHYDROGLUCITOL; COMPLICATIONS;
D O I
10.2337/dc17-2419
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVEIn cystic fibrosis (CF), hemoglobin A(1c) (HbA(1c)) is thought to underestimate glycemia. However, few studies have directly assessed the relationship between HbA(1c) and average glucose in CF. We determined the relationships among glycemic markersHbA(1c), fructosamine (FA), glycated albumin (%GA), and 1,5-anhydroglucitol (1,5-AG)and continuous glucose monitoring (CGM) in CF, hypothesizing that alternate markers would better predict average sensor glucose (ASG) than HbA(1c).RESEARCH DESIGN AND METHODSCF participants and a group of healthy control subjects (HCs), ages 6-25 years, wore CGM for up to 7 days. Pearson correlations assessed the relationships between CGM variables and HbA(1c), FA, %GA, and 1,5-AG. The regression line between HbA(1c) and ASG was compared in CF versus HC. Linear regressions determined whether alternate markers predicted ASG after adjustment for HbA(1c).RESULTSCF (n = 93) and HC (n = 29) groups wore CGM for 5.2 1 days. CF participants were 14 +/- 3 years of age and 47% were male, with a BMI z score -0.1 +/- 0.8 and no different from HCs in age, sex, or BMI. Mean HbA(1c) in CF was 5.7 +/- 0.8% (39 +/- 9 mmol/mol) vs. HC 5.1 +/- 0.2% (32 +/- 2 mmol/mol) (P < 0.0001). All glycemic markers correlated with ASG (P 0.01): HbA(1c) (r = 0.86), FA (r = 0.69), %GA (r = 0.83), and 1,5-AG (r = -0.26). The regression line between ASG and HbA(1c) did not differ in CF versus HC (P = 0.44). After adjustment for HbA(1c), %GA continued to predict ASG (P = 0.0009) in CF.CONCLUSIONSHbA(1c) does not underestimate ASG in CF as previously assumed. No alternate glycemic marker correlated more strongly with ASG than HbA(1c). %GA shows strong correlation with ASG and added to the prediction of ASG beyond HbA(1c). However, we are not advocating use of HbA(1c) for diabetes screening in CF based on these results. Further study will determine whether glycemic measures other than ASG differ among different types of diabetes for a given HbA(1c).
引用
收藏
页码:1406 / 1413
页数:8
相关论文
共 39 条
  • [1] Hyperglycemia and Death in Cystic Fibrosis-Related Diabetes
    Adler, Amanda I.
    Shine, Brian
    Haworth, Charles
    Leelarathna, Lalantha
    Bilton, Diana
    [J]. DIABETES CARE, 2011, 34 (07) : 1577 - 1578
  • [2] [Anonymous], J PEDIAT
  • [3] [Anonymous], 1999, PEDIATR RES, DOI DOI 10.1203/00006450
  • [4] ATER JL, 1983, PEDIATRICS, V71, P810
  • [5] Glycated hemoglobin cannot yet be proposed as a screening tool for cystic fibrosis related diabetes
    Boudreau, Valerie
    Coriati, Adele
    Desjardins, Katherine
    Rabasa-Lhoret, Remi
    [J]. JOURNAL OF CYSTIC FIBROSIS, 2016, 15 (02) : 258 - 260
  • [6] Relationship between glycosylated haernoglobin and mean plasma glucose concentration in cystic fibrosis
    Brennan, Amanda L.
    Gy, Khin M.
    Wood, David M.
    Hodson, Margaret E.
    Geddes, Duncan M.
    Baker, Emma H.
    [J]. JOURNAL OF CYSTIC FIBROSIS, 2006, 5 (01) : 27 - 31
  • [7] Elevation of 1-Hour Plasma Glucose During Oral Glucose Tolerance Testing Is Associated With Worse Pulmonary Function in Cystic Fibrosis
    Brodsky, Jill
    Dougherty, Shayne
    Makani, Ramkrishna
    Rubenstein, Ronald C.
    Kelly, Andrea
    [J]. DIABETES CARE, 2011, 34 (02) : 292 - 295
  • [8] HbA1c as a screening tool for cystic fibrosis related diabetes
    Burgess, Juliana C.
    Bridges, Nicola
    Banya, Winston
    Gyi, Khin M.
    Hodson, Margaret E.
    Bilton, Diana
    Simmonds, Nicholas J.
    [J]. JOURNAL OF CYSTIC FIBROSIS, 2016, 15 (02) : 251 - 257
  • [9] Buse John B, 2003, Diabetes Technol Ther, V5, P355, DOI 10.1089/152091503765691839
  • [10] Continuous glucose monitoring abnormalities in cystic fibrosis youth correlate with pulmonary function decline
    Chan, Christine L.
    Vigers, Timothy
    Pyle, Laura
    Zeitler, Philip S.
    Sagel, Scott D.
    Nadeau, Kristen J.
    [J]. JOURNAL OF CYSTIC FIBROSIS, 2018, 17 (06) : 783 - 790